Artificial Intelligence In Drug Discovery Market Size Worth $3.5 Billion By 2027: Grand View Research, Inc.

Advertisement

BEGIN ARTICLE PREVIEW:

SAN FRANCISCO, Sept. 14, 2020 /PRNewswire/ — The global artificial intelligence in drug discovery market size is expected to reach USD 3.5 billion by 2027, expanding at a CAGR of 28.8%, according to a new report by Grand View Research, Inc. The growing adoption of artificial intelligence (AI) platforms aimed at reducing the overall cost associated with drug discovery and to enhance results is expected to propel the demand for these platforms in the pharma market. Grand View Research LogoMoreKey suggestions from the report:The drug optimization and repurposing segment accounted for the largest revenue share of 54.4% in 2019 By therapeutic area, the oncology segment was valued at USD 125.0 million in 2019 By therapeutic area, the infectious disease segment is expected to witness the fastest growth of 31.4% from 2020 to 2027 In Asia Pacific, the AI in drug discovery market is expected to witness a CAGR of 32.1% from 2020 to 2027 North America and Europe together accounted for 78.6% share of the market revenue in 2019.North America dominated the market with a revenue share of 59.4% in 2019 owing to the increasing adoption of artificial intelligence and the presence of a large number of market players. Asia Pacific is expected to emerge as the fastest-growing region in the market over the forecast period. The …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE